RAC 2.20% $1.78 race oncology ltd

2019 SP, page-117

  1. 1,230 Posts.
    lightbulb Created with Sketch. 60
    yup i still consider bisantrene as “new” because it has never been approved for use by the public in the US. It will still take time to test it in clinical trials.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.